This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centro De Immunologia Molecular. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Maria Eugenia Alonso Biosca: Innovator in Vaccine Biotechnology
Introduction: Maria Eugenia Alonso Biosca is a prominent inventor based in La Habana, Cuba, known for her contributions to the field of biotechnology and human health. With a focus on innovative vaccine formulations, she has developed solutions that significantly enhance immune response without the necessity for additional adjuvants.
Latest Patents: Maria Eugenia holds one notable patent, which is a vaccine composition based on sticholysin encapsulated into liposomes. This invention presents a sophisticated method of utilizing liposomes with multiple lipid layers to deliver toxins from eukaryotic organisms. The encapsulation process involves dehydration and rehydration techniques, producing a lipid composition that balances dipalmitoylphosphatidylcholine and cholesterol in a 1:1 molar ratio. Designed for subcutaneous or intramuscular administration, her innovation stands out for its ability to modulate specific cytotoxic T lymphocyte (CTL) immune responses to various antigens co-encapsulated within the liposomes.
Career Highlights: Throughout her career at the Centro De Inmunología Molecular, Maria Eugenia has been dedicated to advancing vaccine technology. Her work emphasizes the robust nature of the immune response induced by the vaccine vehicle she developed, showcasing its immunomodulating properties, which set it apart from other solutions in the prior art.
Collaborations: Maria Eugenia collaborates with esteemed colleagues such as Maria Eliana Lanio Ruiz and Luis Enrique Fernández Molina. Together, they share a commitment to innovating within the field of biotechnology, fostering a collaborative environment that strengthens their research outcomes.
Conclusion: Maria Eugenia Alonso Biosca exemplifies the spirit of innovation in the biotechnology landscape. Her patented vaccine composition, designed to enhance immune response through advanced encapsulation techniques, positions her as a key figure in the ongoing efforts to improve human health. Through her work at the Centro De Inmunología Molecular, she continues to pave the way for future advancements in vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile